Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Color Diagnostics, |
RCV000581249 | SCV000687364 | likely benign | Hereditary cancer-predisposing syndrome | 2017-05-19 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV003767296 | SCV004671971 | likely benign | Ataxia-telangiectasia syndrome | 2023-08-22 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000581249 | SCV004849058 | uncertain significance | Hereditary cancer-predisposing syndrome | 2015-02-26 | criteria provided, single submitter | clinical testing | The c.2250+13A>G intronic alteration consists of a A to G substitution 3 nucleotides after coding exon 13 in the ATM gene. Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |